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that there may be a useful quantitative relationship
between short-term mutagenicity data and long-
term carcinogenicity data. Not surprisingly, they
conclude that such a relationship is unlikely (at
least that is how I interpreted their guarded
conclusions).
There is an excellent chapter by Carrano and
Moore on methods for quantifying sister-chromatid
exchange in humans. The authors supply some
valuable data which demonstrates the variability of
SCE levels in human peripheral lymphocytes and
emphasise the need for rigorous statistical design of
protocols.
Despite its uneven coverage, this volume will be a
very useful source of reference to anyone interested
in genetic toxicology, and does succeed in
demonstrating the versatility of short-term tests in
allowing investigations which would have been
impossible only one or two decades ago.
S. Venitt,
Institute for Cancer Research,
Pollards Wood Research Station,
Chalfont St. Giles, Bucks.
Prostaglandins and Cancer. (Prostaglandins and
Related Lipids-Vol. 2). (Eds. T. J. POWLES, R. S.
BOCKMAN, K. V. HONN and P. RAMWELL) New
York, Alan R. Liss Inc., 841 pp, 1982.
This book records the proceedings of the "First
International Conference on Prostaglandins and
Cancer" held in 1981 with the stated objective of
bringing together those scientists involved in
prostaglandin research, with those involved in
cancer research. These proceedings indicate that
this objective was fulfilled, although the bias is
towards the biology rather than the chemistry of
the prostaglandins.
It is divided into eight major sections. The first
comprises four review articles which provide an
excellent introduction to the metabolism and
pharmacology of the prostaglandins. The remaining
sections are each divided into review papers and
brief reports. Many of the latter are so insubstantial
as to only add to the bulk of an overlong book
without adding significantly to its value.
The second and third sections cover respectively,
the initiation and promotion phases of
carcinogenesis. The former provides in-depth
reviews on the role of prostaglandin oxygenases in
the synthesis of carcinogenic metabolites, whilst the
latter is concerned with the actual role that the
prostaglandins may play in tumour promotion.
The next two sections concern the role of
prostaglandins in the control of cell replica-
tion/proliferation and cell differentiation/inter-
action. These are followed by a section entitled
Prostaglandins, bone metastases and hypercalcaemia
which closely relates to the following section
covering host-tumour interactions. These two
sections attempt to integrate the relationship and
relative roles of prostaglandins synthesised by the
tumour cell and the host during tumour
progression.
The concluding section, covering the effect of
pharmacological manipulation of prostaglandin
synthesis on tumour growth and metastasis in vivo,
describes potential applications to the treatment of
cancer. The final paper in this section describes the
sole human study and concludes on the depressing
note that the infusion of prostaglandins known to
inhibit tumour cell proliferation in experimental
systems has no effect on the progression of human
cancer. This disappointing result is in contrast to
the work described elsewhere in this book, which
covers an exciting interaction between two areas of
scientific research.
Specialists in the field of prostaglandin research
will probably gain little from this book, but those
oncologists prepared to delve into its 841 pages will
find many papers of interest.
K. Moore,
CRC Medical Oncology Unit,
Southampton General Hospital,
Southampton
Pharmacologic Principles of Cancer Treatment. (Ed.
B. CHABNER) USA, W. B. Saunders Company, 457
pp, 1982, £45.00
Over the last five years there have been a number
of books dealing with the pharmacology of anti-
cancer drugs. Although these have been of interest
there has really been no authoritative volume that
has dealt with this subject in depth. This is the first
time I have had the opportunity to review such a
text and I feel that this will fill a real need for all
those concerned in oncology. The book is divided
into two sections, the first contains excellent
reviews on the principles of cell kinetics,
pharmacokinetics, clinical pharmacology and late
complications of drug therapy. The second section
is devoted to individual chapters on all the
commonly used cytotoxic agents. Each is
comprehensively covered and an authoritative
bibliography appended. Throughout,. the text
presents a unanimity that holds the reader's
attention, diagrams and tables are clearly labelled,
and not overdone. This book should appeal to all
those involved in the care of the patient withBOOK REVIEWS 737
cancer, and whilst it should be present in every
library, the price of £45 should not deter an
individual purchase.
P.M. Wilkinson,
Department of Clinical Pharmacology,
Christie Hospital & Holt Radium Institute,
Manchester
Pancreatic Tumours in Children-Cancer Treatments
and Research, Vol. 2. (Eds G. B. HUMPHREY, G. B.
GRINDEY, L. P. DEHNER, R. T. ACTON and T. J.
PYSHER) The Netherlands, Martinus Nijhoff, 222
pp, 1982, $58.50
This is an extraordinary book. It is the second in a
series to be published annually whose stated
intention is to focus on aspects of paediatric
oncology and related fields which are not well
covered elsewhere. The first section of each volume
is to deal with concepts in research from the basic
sciences and the second section will be devoted to
specific rare tumours and will serve as an informal
tumour registry.
Section one of this volume consists of reviews of
four topics. The first is on the role of natural killer
(NK) cells in resistance to tumours; the others
cover the topics of clonal evolution, cancer cell
differentiation and the clinical significance of
chromosome abnormalities in leukaemia. All are
authoritative and certainly of much topical interest,
but to suggest that none are well covered elsewhere
is a trifle ingenuous.
Section two brings together the available
information on pancreatic malignancies in
childhood, which are indeed excessively rare. There
is a review of the genetic aspects of endocrine
neoplasia and this is followed by a most helpful
review of tumours of the exocrine pancreas in
childhood. The section concludes with a useful
overview of the subject, but much of the material
between takes the form of individual case reports,
often so lacking in detail as to make them
irrelevant.
Any childrens' cancer unit will want to have
access to these volumes for their coverage of the
rarities among paediatric malignancies. However, I
do not think it makes sense to combine the two
sections together in this form. I suspect that those
who might be most interested to read the basic
science reviews in section one are most unlikely ever
to become aware of their existence while they are
hidden in a book with the title Pancreatic Tumours
in Children.
M.G. Mott,
Department of Child Health,
Royal Hospital for Sick Children,
Bristol
Prostate Cancer. (Eds G. H. JACOBI and R.
HOHENFELLNER) USA, Williams and Wilkins, 490
pp, 1982
This is an addition to other texts dealing with this
subject. It brings together the experience of
acknowledged experts in its various chapters and
each of these brings the reader more or less fully up
to date with the state of the art both in respect of
clinical and laboratory expertise and the extent of
research in a number of fields. Each chapter
provides a useful overview on the particular topic
and this, with a good bibliography in each case, is
the main attribute of the book.
As always there are strengths and weaknesses.
There is particularly good coverage of the
epidemiological aspects of this cancer. Perhaps,
however, due to rapid advances in techniques which
have somewhat outstripped the preparation of this
volume, there is scant mention of ultrasonography
of the gland in clinical assessment and virtually
none of the rectal ultrasound techniques. A unique
feature of the book is the editorial comments which
follow most of the chapters a number of which are
contradictory to the line taken by the expert
originally asked by the Editors to contribute the
chapter. This is somewhat confusing for the reader
who is left thereafter to make up his own mind. In
a sense however this sums up the continuing
confusion in the thinking on so many aspects of
this disease.
The book will appeal to specialists in urology
and laboratory and research workers involved with
their clinical colleagues in the study of this disease.
The book is well produced and edited.
N.J. Blacklock,
Department of Urology,
University Hospital of South Manchester,
Manchester 20
Cancer Incidence in 5 Continents, Vol. IV (Eds J.
WATERHOUSE, C. MUIR, K. SHANMUGARATNAM
and J. POWELL) Lyon, IARC Sci. Publications-
No. 42, 812 pp, 1982, $50.00
Cancer is a major health problem all over the
world, not only in developed but also in developing
countries. Many types of cancer show marked
differences in frequency between countries and
between ethnic groups, and such differences can
provide epidemiologists with clues about the causes
of cancer.
This volume contains detailed statistics of cancer
incidence from eighty-one cancer registers covering
various countries or territories in all parts of the
world. For each registry the numbers of cancers per